AddLife AB (OSTO:ALIF B)
kr 118.5 5.5 (4.87%) Market Cap: 14.44 Bil Enterprise Value: 19.70 Bil PE Ratio: 173.85 PB Ratio: 2.67 GF Score: 72/100

Q3 2023 AddLife AB Earnings Call Transcript

Oct 26, 2023 / 07:00AM GMT
Release Date Price: kr62.7 (+11.96%)
Fredrik Dalborg;publ;President;CEO
AddLife AB

()-&

Good morning everyone, and welcome to the Add Life third quarter presentation. Today we will go through some of the business highlights as well as the financials. And then we will open up for questions and discussions.

We're very happy to report a strong growth in the quarter. All the companies are performing very, very well. And in the Labtech business area, we have a 9% organic currency adjusted growth; and in the Medtech business area, 10% organic growth.

We see the healthy demand in all the segments in which we are active. The increased activity in elective surgery remains strong, and we expect that trend to continue in the coming quarters. Positive market trends are supporting our business in home care, in diagnostics and in research. The EBITDA improved, making adjustments for contingent considerations. And that is true in spite of the fact that we have some negative impact from the profitability in AddVision.

The cash flow is significantly improving. We are releasing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot